Albert Cook, MD
Neurology · Johns Creek, GANPI 1891729430
Payments from drug & device makers
Across 724 payments — averaging $457.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$236K
- Argenx US, Inc.$79K
- Pfizer$5K
- Novartis$3K
- Abbott$854
- AstraZeneca$788
- plus $6K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 363 | $236,084 |
| Argenx US, Inc. | 99 | $78,653 |
| Pfizer | 12 | $5,213 |
| Novartis | 46 | $3,251 |
| Abbott | 8 | $854 |
| AstraZeneca(2 entities) | 18 | $788 |
| Biogen | 5 | $620 |
| Teva Pharmaceuticals USA, Inc. | 17 | $582 |
| Sanofi | 10 | $580 |
| AbbVie | 10 | $534 |
| E.r. Squibb & Sons, L.L.C. | 5 | $517 |
| Johnson & Johnson(2 entities) | 5 | $463 |
| EMD Serono, Inc. | 16 | $395 |
| UCB, Inc. | 17 | $327 |
| Amgen | 12 | $322 |
| Amneal Pharmaceuticals LLC | 10 | $277 |
| Globus Medical | 1 | $185 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $181 |
| Grifols USA, LLC | 8 | $161 |
| Eisai Inc. | 9 | $144 |
| Upsher-smith Laboratories LLC | 7 | $130 |
| Vanda Pharmaceuticals Inc. | 5 | $113 |
| MDD US Operations, LLC | 6 | $111 |
| Adamas Pharmaceuticals, Inc. | 5 | $95 |
| Lundbeck LLC | 2 | $51 |
| Avanir Pharmaceuticals, Inc. | 3 | $50 |
| Supernus Pharmaceuticals, Inc. | 3 | $49 |
| Sunovion Pharmaceuticals Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $36 |
| Catalyst Pharmaceuticals, Inc. | 1 | $26 |
| Arbor Pharmaceuticals, Inc. | 2 | $25 |
| Acadia Pharmaceuticals Inc | 1 | $25 |
| Livanova USA, Inc. | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $20 |
| Bristol Myers Squibb | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Impel Pharmaceuticals Inc. | 1 | $12 |
How this compares
$330,969 in reported general payments places this provider in the 90th percentile of 506 neurology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Johns Creek
- Mark HarrisJohns Creek$59K
- Jonathan LissColumbus$25M
- Marshall NashDecatur$13.6M
- James LahAtlanta$6.8M
- Jonathan GlassAtlanta$5.1M
- Sandeep VaidLawrenceville$4.2M
- Allan LeveyAtlanta$4.2M
- Ben ThrowerAtlanta$3.7M
- Jeffrey EnglishAtlanta$3.1M
- Dennis LaceyAtlanta$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.